Overall survival longer compared with standard chemo for disease progression following platinum-based chemo and PD-1 or PD-L1 inhibitor

Use of glycolysis-enhancing drugs terazosin, doxazosin, or alfuzosin tied to lower risk for developing Parkinson disease than use of tamsulosin

Progression-free survival longer and response rate greater for cabozantinib versus sunitinib in phase 2 trial in adults with PRCC

Demographic, community factors show stronger influence than workplace exposure on COVID-19 risk in health care workers

Across states, reductions in PSA screening linked to increased incidence of metastatic prostate cancer at diagnosis

However, data are from survey conducted prior to U.S. emergency use authorization of any vaccines

Health law provides about 23 million people with health insurance, prevents discrimination against preexisting conditions

In small phase II study, 93 percent free of clinically significant prostate cancer at treatment site at five-month biopsy

Reported burnout exists regardless of perceived experiences of mistreatment

Female breast cancer surpassed lung cancer, although lung cancer remained leading cause of cancer deaths in 2020